What is it used for?
SAPHNELO is indicated for the treatment of adult patients with moderate to severe systemic lupus erythematosus (SLE), who are receiving standard therapy. Limitations of Use The efficacy of SAPHNELO has not been evaluated in patients with severe active lupus nephritis or severe active central nervous system lupus. Use of SAPHNELO is not recommended in these situations.SAPHNELO is indicated for the treatment of adult patients with moderate to severe systemic lupus erythematosus (SLE), who are receiving standard therapy. Limitations of Use The efficacy of SAPHNELO has not been evaluated in patients with severe active lupus nephritis or severe active central nervous system lupus. Use of SAPHNELO is not recommended in these situations.
Read the primary sourceThis source does not establish current stock, import permission or personal eligibility in China. The treating clinician and provider must confirm these separately.
Product details
- Active ingredient
- anifrolumab-fniaanifrolumab-fnia
- Form and strength
- INJECTION, SOLUTION · 300 mg / 2.0 mL; INJECTION, SOLUTION · 120 mg / 0.8 mLINJECTION, SOLUTION · 300 mg / 2.0 mL; INJECTION, SOLUTION · 120 mg / 0.8 mL
- Manufacturer / applicant
- ASTRAZENECA PHARMACEUTICALS LPASTRAZENECA PHARMACEUTICALS LP
Intravenous Infusion •Injection: 300 mg/2 mL (150 mg/mL) as a clear to opalescent, colorless to slightly yellow solution in a single-dose vial. Subcutaneous Injection •Injection: 120 mg/0.8 mL as a clear to opalescent, colorless to slightly yellow solution …Intravenous Infusion •Injection: 300 mg/2 mL (150 mg/mL) as a clear to opalescent, colorless to slightly yellow solution in a single-dose vial. Subcutaneous Injection •Injection: 120 mg/0.8 mL as a clear to opalescent, colorless to slightly yellow solution …
Safety and clinical review
- Serious InfectionsSerious Infections
- Hypersensitivity Reactions Including AnaphylaxisHypersensitivity Reactions Including Anaphylaxis
- MalignancyMalignancy
- ImmunizationsImmunizations
- Not Recommended for Concomitant Use with Other Biologic TherapiesNot Recommended for Concomitant Use with Other Biologic Therapies
Ask your clinician to review the complete label, medical history, other medicines, allergies, pregnancy or breastfeeding and any required monitoring. Do not start, stop or change treatment from this page.
Read the primary sourcePrepare your enquiry
Include the brand or generic name, strength, dosage form, requested quantity and country where care is needed. You can attach a prescription when you continue.
Questions patients ask
What is Saphnelo used for?
SAPHNELO is indicated for the treatment of adult patients with moderate to severe systemic lupus erythematosus (SLE), who are receiving standard therapy. Limitations of Use The efficacy of SAPHNELO has not been evaluated in patients with severe active lupus nephritis or severe active central nervous system lupus. Use of SAPHNELO is not recommended in these situations.SAPHNELO is indicated for the treatment of adult patients with moderate to severe systemic lupus erythematosus (SLE), who are receiving standard therapy. Limitations of Use The efficacy of SAPHNELO has not been evaluated in patients with severe active lupus nephritis or severe active central nervous system lupus. Use of SAPHNELO is not recommended in these situations.
This source does not establish current stock, import permission or personal eligibility in China. The treating clinician and provider must confirm these separately.
Which formulation of Saphnelo should I ask about?
INJECTION, SOLUTION · 300 mg / 2.0 mL; INJECTION, SOLUTION · 120 mg / 0.8 mLINJECTION, SOLUTION · 300 mg / 2.0 mL; INJECTION, SOLUTION · 120 mg / 0.8 mL
Read the primary sourceWhat determines the price of Saphnelo?
A current quote depends on the exact presentation, quantity, provider and access arrangements. A catalogue entry is not a stock or delivery promise. Medical charges are paid to the provider, separately from coordination fees.
What should I check before using Saphnelo?
Ask your clinician to review the complete label, medical history, other medicines, allergies, pregnancy or breastfeeding and any required monitoring. Do not start, stop or change treatment from this page.
Sources and review scope
FDA prescribing informationThis source does not establish current stock, import permission or personal eligibility in China. The treating clinician and provider must confirm these separately.